IL-22, IL-31, and IL-33 have been also described to be augmented in IBD, which leads to deregulation of IEC proliferation and migration functions, whereas they stimulate IL-1, TNF-α, IL-6, and IL-8 secretion (49–51). Here, TNF is linked to inflammatory bowel disease.